Recombinant Tafazzin (TAZ)

CMD3A; EFE2; EFE; BTHS; XAP-2; G4.5; Barth syndrome; Endocardial Fibroelastosis 2; Cardiomyopathy,Dilated 3A(X-Linked)

  • Recombinant Tafazzin (TAZ) Packages (Simulation)
  • Recombinant Tafazzin (TAZ) Packages (Simulation)
  • Recombinant Tafazzin (TAZ) Figure. Gene Sequencing (Extract)
  • RPE564Mu01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE of the Recombinant Tafazzin (TAZ)

USAGE of the Recombinant Tafazzin (TAZ)

PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.

STORAGE of the Recombinant Tafazzin (TAZ)

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY of the Recombinant Tafazzin (TAZ)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Related products

Catalog No. Organism species: Mus musculus (Mouse) Applications (RESEARCH USE ONLY!)
RPE564Mu01 Recombinant Tafazzin (TAZ) Positive Control; Immunogen; SDS-PAGE; WB.
PAE564Mu01 Polyclonal Antibody to Tafazzin (TAZ) WB; IHC; ICC; IP.
GUESTBOOK